The Most Favored Patient Act also creates a permanent framework to codify and enforce future cost-saving healthcare agreements as they are reached.
I will create a permanent framework to codify and enforce future cost-saving healthcare agreements.
Occurrences
Evidence
Meuser said he voted for the FY2027 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act, which funds USDA, FDA, and nutrition programs and passed the House 213-210.
Meuser introduced the Most Favored Patient Act, saying it would lower prescription drug costs and save billions of dollars for patients and taxpayers.
Assessments
The available evidence shows a relevant healthcare cost-saving effort, chiefly Meuser’s introduction of the Most Favored Patient Act in March 2026, but not completion of the promised outcome. Introducing a bill is a serious legislative attempt and supports effort credit, yet it does not establish that he created and enacted a permanent framework to codify and enforce future cost-saving healthcare agreements. The later appropriations vote is healthcare-adjacent but temporary and not a permanent enforcement framework. On this record, the promise was pursued but not delivered.